Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9225 |
High Similarity |
NPD7266 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8364 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8232 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8059 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7959 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7929 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD37 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7683 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7671 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7558 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7396 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7254 |
Intermediate Similarity |
NPD228 |
Approved |
0.725 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7066 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5402 |
Approved |
0.6989 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6983 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6975 |
Remote Similarity |
NPD4237 |
Approved |
0.6975 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6972 |
Remote Similarity |
NPD1358 |
Approved |
0.6968 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD7843 |
Approved |
0.6962 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6962 |
Remote Similarity |
NPD1933 |
Approved |
0.6957 |
Remote Similarity |
NPD5763 |
Approved |
0.6957 |
Remote Similarity |
NPD5762 |
Approved |
0.6954 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6946 |
Remote Similarity |
NPD3687 |
Approved |
0.6946 |
Remote Similarity |
NPD3686 |
Approved |
0.6943 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7819 |
Suspended |
0.6941 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD5588 |
Approved |
0.6937 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6933 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD5126 |
Approved |
0.6933 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6928 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6386 |
Approved |
0.6923 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD6385 |
Approved |
0.6909 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6909 |
Remote Similarity |
NPD1511 |
Approved |
0.6908 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6903 |
Remote Similarity |
NPD9494 |
Approved |
0.6903 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6887 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6886 |
Remote Similarity |
NPD5403 |
Approved |
0.6885 |
Remote Similarity |
NPD6842 |
Approved |
0.6885 |
Remote Similarity |
NPD6841 |
Approved |
0.6885 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6879 |
Remote Similarity |
NPD3764 |
Approved |
0.6879 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4538 |
Approved |
0.6875 |
Remote Similarity |
NPD4536 |
Approved |
0.6875 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD3060 |
Approved |
0.6871 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6857 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6852 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6848 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6833 |
Remote Similarity |
NPD7038 |
Approved |
0.6833 |
Remote Similarity |
NPD7039 |
Approved |
0.6829 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD1512 |
Approved |
0.6824 |
Remote Similarity |
NPD7157 |
Approved |
0.6813 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.681 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6805 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6793 |
Remote Similarity |
NPD7906 |
Approved |
0.6792 |
Remote Similarity |
NPD4140 |
Approved |
0.6788 |
Remote Similarity |
NPD7999 |
Approved |
0.6786 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6783 |
Remote Similarity |
NPD3134 |
Approved |
0.6781 |
Remote Similarity |
NPD969 |
Suspended |
0.6771 |
Remote Similarity |
NPD7698 |
Approved |
0.6771 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6771 |
Remote Similarity |
NPD7697 |
Approved |
0.6768 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD5401 |
Approved |
0.6763 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6759 |
Remote Similarity |
NPD3022 |
Approved |
0.6759 |
Remote Similarity |
NPD3021 |
Approved |
0.675 |
Remote Similarity |
NPD447 |
Suspended |
0.6748 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD5772 |
Approved |
0.6744 |
Remote Similarity |
NPD5773 |
Approved |
0.6744 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD7874 |
Approved |
0.6735 |
Remote Similarity |
NPD5535 |
Approved |
0.6735 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6732 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.673 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6728 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6728 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6727 |
Remote Similarity |
NPD3750 |
Approved |
0.6727 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD6273 |
Approved |
0.6725 |
Remote Similarity |
NPD7411 |
Suspended |
0.6719 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6718 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6711 |
Remote Similarity |
NPD4626 |
Approved |
0.6711 |
Remote Similarity |
NPD6671 |
Approved |
0.671 |
Remote Similarity |
NPD3225 |
Approved |
0.671 |
Remote Similarity |
NPD8651 |
Approved |
0.6707 |
Remote Similarity |
NPD6799 |
Approved |
0.6705 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD5353 |
Approved |
0.6705 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6702 |
Remote Similarity |
NPD6781 |
Approved |
0.6702 |
Remote Similarity |
NPD6780 |
Approved |
0.6702 |
Remote Similarity |
NPD6778 |
Approved |
0.6702
|
Remote Similarity |
NPD6782 |
Approved |